Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Financials and The Recent Sell Off
View:
Post by GrahamB on Apr 22, 2023 6:03am

Financials and The Recent Sell Off

 Financials should be due next week, to meet regulatory deadlines.

Many are wondering if the whales selling and sell off reflected a shoe to drop?
 
It should be very interesting to finally see what sales have occurred.

Financials are where the rubber hits the road-all those who kept saying-wait for the next quarter now have there chance to see. COVID is not limiting operations as it was 3 years ago-so lets see
 
The prediction was for 40 units originally, and it will be interesting to see how many of those actually took place.
 
The financials are where we really see what’s happening, since there is a legal obligation to report exactly what’s happening.
 
I will be interested to see what the significance of the changing auditor was, and how that is reflected in the financials, if at all.
 
I see many people questioning, whether or not Sales will be reflected on the accounting statement if they have not received the cash for them. The answer is yes, because companies such as this use, accrual accounting, vs, cash accounting.
 
OK bact to facts:
Sales….
 
JUST FOR CONTEXT 
 
Total revenue for year ending Dec. 31, 2021  = ZERO
 
Total revenue for year ending Dec. 31, 2020  = $36,017
 
Total revenue for year ending Dec. 31, 2019  = $81,023
 
Total revenue for year ending Dec. 31, 2018  = $60,177
 
ALL DATA FROM SEDAR.COM
 
Any predictions on the number of sales?
 
The initial target were revised from 75-100 units in FY2022 to 40-45 units.
 
From ceo-many seem to be mesmerized by cardinal who said 
“@cardinal They will have roughly 45 sales by year end. Q1 and 2 will be very very large. They will be way past the number that draws attention from buyers.’ 
 
Here is the guidance from the company :
1. Nine distributors appointed in USA to cover the entire country to join UK and European distributors for a total of 11 distributors,  
3. Sales team now has 33 sales and marketing representatives across the USA, Europe and UK, 
 
 
 
With the assistance of our distributors and our internal sales force, the Company now has a list of over 4,000 cardiologists who have a practice where the VMS+ would improve their ability to assess and monitor their patients In addition, our sales team (direct and distributor) already have a relationship with all these potential customers in US, UK and Europe.  Hence, the Company now has a full funnel of leads. Our sales team has been actively scheduling appointments to make them aware of the clinical benefits of the VMS+.
 
 
https://www.thenewswire.com/press-releases/1Av7FPeNe-ventripoint-diagnostics-provides-a-corporate-update-and-announces-new-investor-relations-initiative.html
 
We Heard chatter here of” 100% conversion” rate 

Lets see shall we
 
Comment by jopatclo on Apr 22, 2023 7:35am
This post has been removed in accordance with Community Policy
Comment by GrahamB on Apr 22, 2023 7:58am
For once, Just once, Jopatchie try to have an original thought Even try posting a thought (or reposting others thoughts from CEO) that is aligned logically with the post Otherwise it seems like you are a bot that's is unhinged... or an individual that has cognitive challenges, or is it a language barrier? Seriously if thats it-put your post in French and we can read it. Otheerwise its just ...more  
Comment by woundedknee on Apr 24, 2023 4:13pm
I left this stock when we were told that their was enough money for two years and then a week or two later they executed a private placement. That was my exit point. gl
Comment by chry200030 on Apr 24, 2023 6:20pm
Good for you.  The proof will be in the pudding..! Things don't happen as quickly as we would like in these plays.  That's why one must calculate the risk/reward ratio.  Not everyone has the same risk.reward ratio, so your opinion is only yours and no one else. You see more risk with little reward so you sold. Good for you.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities